Partnership Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
A recent court ruling excluding LDTs from FDA regulation highlights the urgent need for the diagnostics industry to modernize oversight.
Join our mailing list to receive the latest news and updates from our team.
mNGS significantly improves pathogen detection in pulmonary infections, enabling more precision compared to conventional methods.
Festo's SupraMotion uses superconducting technology to enable automated, contactless handling across sterile and non-sterile environments.
Foresight Diagnostics announced the independent validation of its CLARITY MRD assay, showing strong prognostic performance.